Cannabis Law Report

DECEMBER 18, 2019

. …MGC Pharmaceuticals has achieved yet another significant milestone with the bio-pharma company this week surpassing more than 1,800 prescribed products of its medicinal cannabis-based pharmaceutical products in Australia, UK, Brazil and Ireland. Source: [link].

Research and Development 59

Research and Development Clinical Trials Seed-To-Sale Pharmaceutical 59

Cannabis Law Report

APRIL 10, 2019

He added, “I welcome the trials and I welcome the review, but, sadly, people need these medicines now. My sympathies go out to the patients and their families who are desperately seeking to alleviate their symptoms with medicinal cannabis. Can we unlock the door?”. We are working hard to get the right approach.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

The Cannigma

DECEMBER 22, 2021

We have autism and epilepsy. We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil. They have what they call a herbal medicine. We see cannabis as a real medicine. We have, I think, eight PhDs.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. No hepatic side effects were noted.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

OCTOBER 17, 2019

Selinger cites software, point-of-sale systems, and packaging as areas that are thriving in the state. Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. alcoholic beverages, caffeine, and tobacco).

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

DECEMBER 30, 2019

For the first time, the FY 2020 Appropriations package contained this protection for 47 states within the base language of the text. Included in the final FY 2020 spending package). Specifically, it expands the pool of patients eligible for cannabis therapy to include those with chronic pain, menstrual cramps, and epilepsy.

Legislation 59

Legislation Patients Access Banking 59